Company intelligence / Profile preview

AlphaQ Venture Capital

Ownership: Private
Employees: ~10
Development stage: Other

Overview

AlphaQ Venture Capital (AQVC) is a Germany-based venture capital fund of funds. It democratizes access to top-performing VC funds worldwide by allowing investors to buy shares in an evergreen stock corporation structure. AQVC invests primarily in early-stage technology-focused VC funds across Europe, Israel, and the United States. The firm targets diversification and risk mitigation for its investors by allocating capital across 50-60 leading VC funds that collectively back over 1,200 startups.[4][7] There are no clinical results as the company does not develop drugs or medical products.

Industry: Investors

Partnerships

Invests in top-tier VCs such as Northzone, Partech, Speedinvest, Headline, etc.

Beyond the preview

Go deeper on AlphaQ Venture Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AlphaQ Venture Capital.

Explore the full profile